ClinicalTrials.gov
public full text
Public Domain
Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer
Current therapies for metastatic or unresectable Colon Cancer provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of metastatic or unresectable Colon Cancer. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with metastatic or unresectable Colon Cancer
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study#879099
- Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments#1047516
- Interleukin-2 in Metastatic Melanoma#904589
- Improving Glucose and Lipid Metabolism Through Caloric Restriction Using Diet or Surgery (CRUDOS)#839732
- NEOSENT: Early Anti-PD-1 Therapy In High-Risk Stage II Melanoma#980242
Record · ID 838108
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive